Literature DB >> 11239193

111In platelet scintigraphy for the noninvasive detection of carotid plaque thrombosis.

G Manca1, G Parenti, R Bellina, G Boni, M Grosso, W Bernini, C Palombo, M Paterni, G Pelosi, M Lanza, N Mazzuca, R Bianchi, R De Caterina.   

Abstract

BACKGROUND AND
PURPOSE: Thrombosis on atherosclerotic lesions in the large extracranial arteries is the main cause of embolization in the distal cerebral circulation and thus is involved in the pathogenesis of ischemic stroke. The assessment of biological characteristics of lesions that are predictive of thrombotic complications might help in stratification of the risk for stroke but is currently imperfect.
METHODS: We compared the performance of (111)In-platelet scintigraphy with blood pool subtraction, ultrasound-based tissue texture analyses, and transcranial Doppler techniques in their ability to predict the occurrence of superficial thrombosis or the presence of a lipid pool in carotid artery plaque specimens removed at the time of carotid endarterectomy in 22 patients with unilateral carotid artery stenosis of >70%.
RESULTS: Positivity at (111)In-platelet scintigraphy was present in 8 patients and correctly identified the presence of thrombosis superimposed on a complicated plaque. Neither tissue texture analysis nor emboli detection by transcranial Doppler, performed in 12 patients, significantly identified plaque thrombosis. None of the techniques used were able to detect the presence of a significant lipid pool inside the plaque.
CONCLUSIONS: Indium-platelet scintigraphy is an accurate noninvasive diagnostic tool to detect thrombotic complications in carotid plaques. Prospective studies should assess its ultimate value in risk stratification, possibly to guide the decision of whether to perform endarterectomy in selected patient categories.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239193     DOI: 10.1161/01.str.32.3.719

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

Review 1.  Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.

Authors:  Shann S Yu; Ryan A Ortega; Brendan W Reagan; John A McPherson; Hak-Joon Sung; Todd D Giorgio
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-10

Review 2.  Recent Advances in the Development of PET/SPECT Probes for Atherosclerosis Imaging.

Authors:  Yoichi Shimizu; Yuji Kuge
Journal:  Nucl Med Mol Imaging       Date:  2016-04-26

3.  Imaging High-Risk Atherothrombosis Using a Novel Fibrin-Binding Positron Emission Tomography Probe.

Authors:  Peter Caravan; Ilknur Ay; David Izquierdo-Garcia; Himashinie Diyabalanage; Ian A Ramsay; Nicholas J Rotile; Adam Mauskapf; Ji-Kyung Choi; Thomas Witzel; Valerie Humblet; Farouc A Jaffer; Anna-Liisa Brownell; Ahmed Tawakol; Ciprian Catana; Mark F Conrad
Journal:  Stroke       Date:  2021-12-30       Impact factor: 7.914

Review 4.  Molecular imaging in atherosclerosis.

Authors:  Andor W J M Glaudemans; Riemer H J A Slart; Alessandro Bozzao; Elena Bonanno; Marcello Arca; Rudi A J O Dierckx; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-20       Impact factor: 9.236

5.  In vivo and in vitro evidence that ⁹⁹mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery.

Authors:  Andor W J M Glaudemans; Elena Bonanno; Filippo Galli; Clark J Zeebregts; Erik F J de Vries; Michel Koole; Gert Luurtsema; Hendrikus H Boersma; Maurizio Taurino; Riemer H J A Slart; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-16       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.